Email bulletin archive Archive December 2019 New US guidelines recommend screening of all adults for hepatitis C A healthy lifestyle could prevent most liver cancer and liver-related deaths Global burden of deaths and liver cancer due to non-alcoholic fatty liver disease growing Immunotherapy combination improves liver cancer survival Combination therapies show promise against hepatitis D Is this your copy of the infohep news bulletin? November 2019 News from The Liver Meeting Coalition of liver associations calls for simplification of hepatitis C care Liver cancer survival after DAA treatment Organ transplants from donors with hepatitis C Hepatitis C incidence in Canadian men who have sex with men on PrEP Treatments for NASH Hepatitis B: antivirals reduce liver cancer risk Therapeutic vaccine for hepatitis B Is this your copy of the infohep news bulletin? October 2019 Tesamorelin reduces liver fat and fibrosis progression in people with HIV and NAFLD People who use drugs would prefer to get hepatitis C treatment at a community pharmacy Trivalent hepatitis B vaccine appears more effective than existing options Hepatitis C vaccine fails to prevent chronic infection Shifting demographics of the population of people with hepatitis C in the United States Arbutus halts early-phase hepatitis B drug trial after 2 healthy people fall ill Gilead faces drug pricing probe in Brazil News coverage of The Liver Meeting 2019 Is this your copy of the infohep news bulletin? September 2019 Non-alcoholic fatty liver disease: scientists call for sugar tax NAFLD raises the risk of cancer in overweight people Fatty liver raises the risk of death in people with HIV and hepatitis C Does hepatitis C virus remain in the body after successful treatment? Curing hepatitis C may reduce inflammation in people living with HIV Hepatitis C undiagnosed in England New report calls for organisations involved with hepatitis C testing, treatment and care to improve data sharing Is this your copy of the infohep news bulletin? August 2019 FDA warns of rare cases of serious liver injury with newer hepatitis C drugs Voluntary licensing of hepatitis C drugs has led to more people on treatment Late diagnosis of hepatitis C Hepatitis B raises the risk of some cancers Young adults with vertical HIV and hepatitis C co-infection have a high hepatitis C cure rate 13% of HIV-positive Europeans who are cured of hepatitis C are reinfected Statins linked to lower risk of liver cancer in people with hepatitis B or C San Francisco sees new success in treating homeless people with hepatitis C Is this your copy of the infohep news bulletin? July 2019 WHO urges countries to invest in eliminating hepatitis 15 million affected by hepatitis in Pakistan World Hepatitis Day masterclasses Treatment in primary care improves the uptake of treatment in people who inject drugs UK Pharmacy Minister urged to allow pharmacist dispensing of DAAs Heart disease and cancers in people with HIV and hepatitis C co-infection Is this your copy of the infohep news bulletin? June 2019 African hepatitis summit Egypt to provide hepatitis C testing, treatment for 14 countries Opioid substitution prescribers and DAA treatment Pangenotypic treatment in France How much can 'Netflix'-style pricing for hepatitis C drugs save? Parkinson’s disease risk in people treated for hepatitis C Hepatitis C stigma Liver cancer screening Hepatitis C vaccine not effective Is this your copy of the infohep news bulletin? May 2019 World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans Bulevirtide is a potential cure for hepatitis B and D Is opt-out testing for HCV improving testing rates in UK prisons? First paediatric pangenotypic treatment NHS England strikes world leading deal to help eliminate hepatitis C NHS England instructs GPs to do more hepatitis C testing after blood scandal Is this your copy of the infohep news bulletin? April 2019 News from The International Liver Congress, Vienna Hepatitis C elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment 30 million screened for hepatitis C in four months in Egypt Same-day diagnosis and treatment initiation for viral hepatitis Hepatitis B cure strategy launched Experimental hepatitis B drug produces deep and rapid decline in HBV DNA Non-alcoholic fatty liver disease and NASH NAFLD in people living with HIV Simplified monitoring and highly effective treatment for hepatitis C Tenofovir and liver cancer in HBV Is this your copy of the infohep news bulletin? March 2019 Hepatitis C drops among HIV-positive London gay men after direct-acting antiviral scale-up HCV reinfection in people who inject drugs a sign of a successful treatment programme, say researchers US Department of Veterans Affairs on track to cure 100,000 of hepatitis C Hepatitis C treatment reduces risk of diabetes Hepatitis C treatment safe and effective in pregnant women, pilot study shows Hepatitis B virus raises the risk of age-related macular degeneration EndHep2030 call for proposals World Hepatitis Alliance appoints new CEO and President Next month: News from The International Liver Congress Is this your copy of the infohep news bulletin? February 2019 DAA treatment reduces the risk of death and liver cancer in France Experimental therapy improves liver health in people with fatty liver disease Immunotherapy combinations show promise for liver cancer Generic treatment and hepatitis C elimination in Egypt Hepatitis C cure does not improve long-term glucose control Tackling HIV and hepatitis C in Europe: towards minimum standards Improving the uptake of hepatitis C care in people who inject drugs Is this your copy of the infohep news bulletin? January 2019 Lancet Commission recommends actions to support elimination of hepatitis C HCV modelling study HIV/HCV co-infection and end-stage liver disease Survival after liver cancer diagnosis is shorter in people living with HIV Conditional cash transfers to encourage hepatitis C diagnosis and treatment in people who inject drugs Barriers to HCV treatment in people who inject drugs TAF for hepatitis B AbbVie legal challenge in UK tender exercise dismissed Is this your copy of the infohep news bulletin? 2022202120202019201820172016201520142013 Other pages in this section Latest news All the news Conference news Email bulletin archive